Estrella Immunopharma Inc. (NASDAQ: ESLAW) — Healthcare · Share Price, Chart & Market Data
About: Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidates include EB103 for the treatment of diffuse large B-cell lymphoma and is in pre clinical trial; and EB104 to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia. It has a collaborative partnership with Imugene Limited for the development of solid tumor treatments using Imugene's product candidate CF33-CD19t in conjunction with EB103. Estrella Immunopharma, Inc. is based in EmeryVille, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.12 (+21.20%)
ESLAWEstrella Immunopharma Inc.
Loading watchlist status…
Trade ESLAW now
Estrella Immunopharma Inc. share price
ESLAW price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 7:33 am GMT+0
ESLAW price performance
0%
5D
61.6%
1M
96.753%
YTD
40.93%
1Y
ESLAW price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 7:33 am GMT+0
ESLAW details
ESLAW Market Signals